8-(3-(<i>R</i>)-Aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a Highly Potent, Selective, Long-Acting, and Orally Bioavailable DPP-4 Inhibitor for the Treatment of Type 2 DiabetesMatthias Eckhardt, Frank Himmelsbach, Elke Langkopf et al.|Journal of Medicinal Chemistry|2007Cited by 285
Structural Characterization of Three Crystalline Modifications of Telmisartan by Single Crystal and High‐Resolution X‐ray Powder DiffractionRobert E. Dinnebier, William I. F. David, Herbert Nar et al.|Journal of Pharmaceutical Sciences|2000Cited by 68
CCDC 209545: Experimental Crystal Structure DeterminationRobert E. Dinnebier, William I. F. David, Peter Sieger et al.|The Cambridge Structural Database|2003Cited by 0
CCDC 209544: Experimental Crystal Structure DeterminationRobert E. Dinnebier, William I. F. David, Peter Sieger et al.|The Cambridge Structural Database|2003Cited by 0
CCDC 209546: Experimental Crystal Structure DeterminationRobert E. Dinnebier, William I. F. David, Peter Sieger et al.|The Cambridge Structural Database|2003Cited by 0